Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Chem Commun (Camb) ; 52(7): 1466-9, 2016 Jan 25.
Artigo em Inglês | MEDLINE | ID: mdl-26649616

RESUMO

In comparison to iron(ii) halides, iron(ii) triflate exhibits a greater resistance towards reduction by p-tolylmagnesium bromide. This knowledge has led to the development of an iron(ii) triflate/N-heterocyclic carbene-catalysed cross-coupling system of aryl Grignard reagents with aryl chlorides and tosylates with high efficiency, even surpassing that of previously reported catalyst systems employing strongly coordinating counterions in some cases.

2.
J Med Chem ; 58(3): 1400-19, 2015 Feb 12.
Artigo em Inglês | MEDLINE | ID: mdl-25627172

RESUMO

To develop novel neuroprotective agents, a library of novel arylalkenylpropargylamines was synthesized and tested for inhibitory activities against monoamine oxidases. From this, a number of highly potent and selective monoamine oxidase B inhibitors were identified. Selected compounds were also tested for neuroprotection in in vitro studies with PC-12 cells treated with 6-OHDA and rotenone, respectively. It was observed that some of the compounds tested yielded a marked increase in survival in PC-12 cells treated with the neurotoxins. This indicates that these propargylamines are able to confer protection against the effects of the toxins and may also be considered as novel disease-modifying anti-Parkinsonian agents, which are much needed for the therapy of Parkinson's disease.


Assuntos
Inibidores da Monoaminoxidase/farmacologia , Monoaminoxidase/metabolismo , Fármacos Neuroprotetores/farmacologia , Pargilina/análogos & derivados , Doença de Parkinson/tratamento farmacológico , Propilaminas/farmacologia , Animais , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Relação Dose-Resposta a Droga , Humanos , Camundongos , Estrutura Molecular , Inibidores da Monoaminoxidase/síntese química , Inibidores da Monoaminoxidase/química , Fármacos Neuroprotetores/síntese química , Fármacos Neuroprotetores/química , Células PC12 , Pargilina/síntese química , Pargilina/química , Pargilina/farmacologia , Doença de Parkinson/enzimologia , Doença de Parkinson/metabolismo , Propilaminas/síntese química , Propilaminas/química , Ratos , Relação Estrutura-Atividade
3.
Chem Commun (Camb) ; 50(61): 8424-7, 2014 Aug 07.
Artigo em Inglês | MEDLINE | ID: mdl-24947849

RESUMO

A catalyst system comprising Fe2(O(t)Bu)6 and an N-heterocyclic carbene ligand enables efficient syntheses of (hetero)biaryls from the reactions of aryl Grignard reagents with a diverse spectrum of (hetero)aryl chlorides. Amongst the alkoxide and amide counterions investigated, tert-butoxide was the most effective in inhibiting the homocoupling of arylmagnesiums.


Assuntos
Compostos Férricos/química , Metano/análogos & derivados , Amidas/química , Catálise , Complexos de Coordenação/química , Compostos Heterocíclicos/química , Metano/química , Óxidos/química
4.
Org Lett ; 14(13): 3550-3, 2012 Jul 06.
Artigo em Inglês | MEDLINE | ID: mdl-22702395

RESUMO

A synthetic method of azaspirocyclohexadienones has been developed through copper-catalyzed aerobic spirocyclization of biaryl-N-H-imines prepared by the reaction of biarylcarbonitriles and Grignard reagents.


Assuntos
Compostos Aza/química , Cobre/química , Cicloexenos/química , Iminas/síntese química , Compostos Organometálicos/química , Compostos de Espiro/química , Catálise , Ciclização , Iminas/química , Conformação Molecular , Oxigênio/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...